v3.25.2
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2025
Dec. 31, 2024
Assets    
Cash and due from banks $ 101,272 $ 114,055
Federal funds sold 734 711
Cash and cash equivalents 102,006 114,766
Investment securities available for sale, at fair value 1,364,201 1,207,574
Equity securities, at fair value 4,204 4,792
Loans 5,018,053 5,167,574
Allowance for credit losses on loans (105,176) (111,204)
Total loans, net 4,912,877 5,056,370
Loans held for sale 287,821 344,947
Premises and equipment, net 86,719 85,710
Other real estate owned 4,183 4,941
Nonmarketable equity securities 44,542 33,723
Accrued interest receivable 24,269 25,329
Loan servicing rights, at lower of cost or fair value 17,278 17,842
Goodwill 7,927 161,904
Other intangible assets, net 11,189 12,100
Company-owned life insurance 212,336 211,168
Credit enhancement asset 5,615 16,804
Other assets 199,637 208,839
Total assets 7,284,804 7,506,809
Deposits:    
Noninterest-bearing demand deposits 1,090,707 1,055,564
Interest-bearing deposits 4,845,727 5,141,679
Total deposits 5,936,434 6,197,243
Short-term borrowings 40,224 87,499
Federal Home Loan Bank advances and other borrowings 498,000 258,000
Subordinated debt 77,754 77,749
Trust preferred debentures 51,358 51,205
Accrued interest payable and other liabilities 109,597 124,266
Total liabilities 6,713,367 6,795,962
Shareholders’ Equity:    
Preferred stock, $2.00 par value; 4,000,000 shares authorized; 115,000 Series A shares, $1,000 per share liquidation preference, issued and outstanding at March 31, 2025 and December 31, 2024, respectively 110,548 110,548
Common stock, $0.01 par value; 40,000,000 shares authorized; 21,503,036 and 21,494,485 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively 215 215
Capital surplus 435,299 434,346
Retained earnings 97,714 247,698
Accumulated other comprehensive loss, net of tax (72,339) (81,960)
Total shareholders’ equity 571,437 710,847
Total liabilities and shareholders’ equity $ 7,284,804 $ 7,506,809